Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug381 | Asynchronous self-directed digital training Wiki | 1.00 |
| drug4797 | vaccine Wiki | 1.00 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The goal of this single-blind, randomized controlled pilot study is to evaluate the acceptability and feasibility of an Interpersonal Psychotherapy (IPT) asynchronous self-directed digital training platform for psychiatry residents, as compared to synchronous large group online workshop teaching. This study has the potential to improve access to competency-based training and dissemination of IPT, impacting healthcare delivery with increasing access to this evidence-based psychological depression treatment.
Description: Number recruited per site per month for the intervention arm vs the control arm
Measure: Recruitment rate - resident and patient participants Time: 1.5 year recruitment periodDescription: Percentage of patient and resident participants retained and assessed with valid primary outcome data for the intervention vs control.
Measure: Retention rate - resident and patient participants Time: two yearsDescription: Percentage of resident participants who complete the online modules and homework assignments for the intervention vs control.
Measure: Participation rate - resident participants Time: Assessed throughout the 2-3 weeks training period.Description: We will assess acceptability by conducting a process evaluation; this will take the form of semi-structured interviews with all residents in the intervention to explore experiences of learning through the asynchronous self-directed online curriculum and platform along with facilitators and barriers to attaining the learning objectives of achieving competency in delivering IPT.
Measure: Acceptability of the intervention Time: Immediately after resident participants' final session with their IPT patient.Description: Depressive symptoms as measured by the Patient Health Questionnaire-9 (PHQ-9), a self-rating instrument that assesses symptoms of depression experienced during the past 2 weeks and is based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for MDD. Each of the nine items includes four possible responses related to symptom duration (e.g. not at all to nearly every day). Scores ≥10 (scale range 0-27) are often used to identify major depression.
Measure: Depression - patient participant Time: up to 12 weeksDescription: Anxiety symptoms as measured by the General Anxiety Disorder-7 scale (GAD-7). The GAD-7 is a 7-item, self-rated scale developed as a screening tool and severity indicator for Generalized Anxiety Disorder. Items are rated on a 4-point Likert-type scale (0 = not at all to 3 = nearly every day). Scores range from 0 to 21 with higher scores indicating more severe GAD symptoms.
Measure: Anxiety - patient participant Time: up to 12 weeksDescription: Resident participants will fill in a measure of their global impression of their patient's improvement via the Clinical Global Impressions of Improvement (CGI-I) scale. This is a clinician rated scale that assesses the extent of clinical change in the patient at the point of assessment compared with baseline, and has a 7-point range, from 'Very much improved' 1 to 'Very much worse' 7. Higher scores signify greater severity and/or worse outcomes. The CGI-I has been found to be highly sensitive to change.
Measure: Patient improvement - resident participant Time: up to 12 weeksDescription: The Working Alliance Inventory-Short Revised (WAI-SR) is used by psychotherapists to assess and measure the therapeutic alliance for supervision and research purposes. The WAI-SR is a 12- item scale and consists of three subscales that measure three aspects of the therapeutic alliance: goals (agreement on the goals of therapy), tasks (agreement on the agenda of the therapy) and affective bond (development of relational bond between the client and the therapist). Each item is rated on a 7- point scale ranging from 1 (never) to 7 (always).
Measure: Therapeutic alliance - patient participants Time: At week 3 and week 12.Description: The Brief IPT Checklist (BIC) will assess therapy quality. Developed by the study PI and used in other IPT-training initiatives in Ethiopia, China and Canada, this 15-item checklist includes essential IPT therapist behaviours across all sessions and within specific phases (beginning, middle or end). Response options for each item are recorded on a Likert scale of 0 (not done) to 4 (excellent). For consenting resident and patient pairs, each IPT therapy session will be audio recorded, and 1 randomly chosen from each of the early (sessions 1-2), middle (sessions 3-10) and late (sessions 11-12) phases of the therapy will be rated by independent experts in IPT (not study supervisors) and the resident therapist (after each therapy session) using the BIC.
Measure: Therapy quality - resident participant Time: up to 12 weeksDescription: IPT knowledge will be measured by a 25-item quiz derived from principles of IPT. The quiz will include case-based multiple-choice and short-answer questions that examine the trainees understanding of phase- and focus-specific therapeutic guidelines of IPT.
Measure: IPT knowledge - resident participant Time: Baseline and at 12 weeks.Description: Counselling self-efficacy will be measured by using the counselling self-estimate inventory (COSE). It is a 42-item scale and includes both positive and negative statements about counselling self-efficacy. Respondents are asked to rate on a 6-point Likert scale from 1 (strongly disagree) to 6 (strongly agree) how they would perform in a counselling situation at the present time. The higher the score the stronger perception of counselling self-efficacy.
Measure: Counseling self-efficacy - resident participant Time: Baseline and the 12-week course of therapy.Description: Resident participants will be assessed for competency through structured role plays using the investigator-developed Brief IPT Checklist (BIC) Using standardized patients, there will be two vignettes per resident on 2 differing IPT focal areas of social role transitions and disputes which will be rated by two experts in IPT (not study supervisors) on IPT-specific and general psychotherapy skills, on a scale of 0 (not done) to 2 (done well). The average score between the two role plays will be selected as a measure of the trainee competence. After the role play is finished, the standardized patients will be asked four questions to assess their impression of the resident participant's performance, and whether they would want to return for psychotherapy treatment with the resident.
Measure: Resident competence - resident participant Time: Immediately after the intervention.Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports